---
title: "Kenrik Industries Ltd (544398) — Share Price, Financials & Analysis"
symbol: "544398"
company: "Kenrik Industries Ltd"
canonical: "https://tapetide.com/stocks/544398"
isin: "INE0AOG01018"
nse_symbol: "KENRIKINDUSTRIESLTD"
bse_code: "544398"
sector: "Consumer Goods"
industry: "Jewellery & Watches"
market_cap_cr: 17.11
generated_at: "2026-09-13T18:22:57.375Z"
---

# Kenrik Industries Ltd (544398)

Canonical page: https://tapetide.com/stocks/544398

## Company

- **NSE Symbol:** KENRIKINDUSTRIESLTD
- **BSE Code:** 544398
- **ISIN:** INE0AOG01018
- **Sector:** Consumer Goods
- **Industry:** Jewellery & Watches
- **Macro Sector:** Consumer Discretionary
- **Stock Type:** EQUITY
- **Listed Since:** 2025-05-09
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** kenrikindustries.net

## About

Incorporated in 2017, Kenrik Industries Ltd 
is in the business of Trading of Gold and 
Silver Ornaments & Bullion.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:49:44.750083Z.

- **Market Cap:** ₹17.11 Cr
- **Classification:** SME
- **P/E (reported):** 0
- **Book Value:** ₹17.87
- **Price to Book:** 0.73
- **Dividend Yield:** 0%
- **ROE:** -0.02%
- **ROCE:** 0.24%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹80.2 Cr
- **Net Income:** ₹0 Cr
- **EBITDA:** ₹0.1 Cr
- **52-Week High:** ₹13.07
- **52-Week Low:** ₹5.55
- **RSI (14):** 79.38

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.77 times its book value

### Weaknesses

- Company has a low return on equity of 4.78% over last 3 years.
- Debtor days have increased from 28.6 to 60.3 days.
- Working capital days have increased from 70.5 days to 101 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -277.87% | -534.55% | -98.34% |
| ebitda margin growth | -96.02% | -96.04% | -94.16% |
| net income growth | -100% | -100% | -100% |
| revenue growth | 7.22% | 16% | 16% |
| roce | -97.81% | -97.87% | 6.55% |
| roe | -100.27% | 5.26% | -100.57% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 40.11 | 21.8 | 52.94 | 22.13 | 58.06 |
| Expenses | 40.22 | 21.28 | 52.01 | 21.34 | 58.79 |
| Operating Profit | -0.11 | 0.52 | 0.93 | 0.79 | -0.73 |
| OPM % | -0.27 | 2.39 | 1.76 | 3.57 | -1.26 |
| Other Income | 0.17 | 0.03 | 0.01 | 0 | 0.01 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.05 | 0.55 | 0.93 | 0.78 | -0.73 |
| Tax % | -20 | 34.55 | 32.26 | 25.64 | -19.18 |
| Net Profit | 0.05 | 0.36 | 0.63 | 0.58 | -0.59 |
| EPS in Rs | 0.06 | 0.4 | 0.7 | 0.46 | -0.47 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 32.3 | 38.86 | 39.95 | 51.88 | 70.77 | 74.74 | 80.2 |
| Expenses | 32.03 | 38.5 | 39.5 | 51.37 | 69.51 | 73.28 | 80.15 |
| Operating Profit | 0.27 | 0.36 | 0.45 | 0.51 | 1.26 | 1.46 | 0.05 |
| OPM % | 0.84 | 0.93 | 1.13 | 0.98 | 1.78 | 1.95 | 0.06 |
| Other Income | 0.07 | 0.17 | 0.1 | 0.16 | 0.17 | 0.04 | 0.01 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.31 | 0.51 | 0.53 | 0.65 | 1.42 | 1.49 | 0.05 |
| Tax % | 25.81 | 25.49 | 26.42 | 27.69 | 23.94 | 32.89 | 120 |
| Net Profit | 0.23 | 0.37 | 0.39 | 0.47 | 1.07 | 0.99 | 0 |
| EPS in Rs | — | — | 0.43 | 0.52 | 1.19 | 1.1 | 0 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5 | 5 | 9 | 9 | 9 | 9 | 12.5 |
| Reserves | 0.48 | 0.87 | 2.06 | 2.54 | 3.6 | 4.6 | 9.84 |
| Borrowings | 0.11 | 0.13 | 0.16 | 0.57 | 0.78 | 1.06 | 0.2 |
| Other Liabilities | 1.77 | 4.26 | 1.24 | 3.49 | 2.39 | 3.08 | 3.87 |
| Total Liabilities | 7.36 | 10.26 | 12.46 | 15.6 | 15.77 | 17.74 | 26.41 |
| Fixed Assets | 0.13 | 0.1 | 0.1 | 0.08 | 0.06 | 0.05 | 0.04 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 7.23 | 10.16 | 12.36 | 15.52 | 15.71 | 17.69 | 26.37 |
| Total Assets | 7.36 | 10.26 | 12.46 | 15.6 | 15.77 | 17.74 | 26.41 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | -0.01 | -4.82 | 0.29 | 2.2 | -2.53 | -9.56 |
| Cash from Investing Activity | — | 0 | -0.01 | -0.51 | 0.38 | -0.24 | 0.72 |
| Cash from Financing Activity | — | 0.02 | 4.83 | 0.22 | 0.07 | 0.29 | 8.75 |
| Net Cash Flow | — | 0 | -0.01 | 0 | 2.65 | -2.48 | -0.1 |
| Free Cash Flow | — | -0.01 | -4.83 | 0.29 | 2.2 | -2.53 | -9.56 |
| CFO/OP | — | 33 | -1040 | 84 | 203 | -140 | -19020 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 26.67 | 13.81 | 38.46 | 29.48 | 9.18 | 16.31 | 60.3 |
| Inventory Days | — | 80.86 | 64.99 | 71.71 | 56.74 | 67.09 | 58.22 |
| Days Payable | — | 39.19 | 10.13 | 19.99 | 9.77 | 11.79 | 3.84 |
| Cash Conversion Cycle | 26.67 | 55.47 | 93.32 | 81.2 | 56.16 | 71.61 | 114.68 |
| Working Capital Days | 61.59 | 55.23 | 101.51 | 76.97 | 48.69 | 61.78 | 101.08 |
| ROCE % | — | 8.8 | 6.16 | 5.57 | 11.14 | 10.63 | 0.27 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2024 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Promoters | 100% | 72.01% | 72.01% |
| FIIs | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% |
| Government | 0% | 0% | 0% |
| Public | 0% | 25.59% | 25.4% |
| Others | 0% | 2.4% | 2.59% |
| No. of Shareholders | 8 | 427 | 383 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 3 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 11.1 | Buy |
| EMA (10) | 11.35 | Buy |
| SMA (20) | 9.18 | Buy |
| EMA (20) | 10.1 | Buy |
| SMA (50) | 8.79 | Buy |
| EMA (50) | 9.24 | Buy |
| SMA (100) | 9.06 | Buy |
| EMA (100) | 9.91 | Buy |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 81.32 | Sell |
| MACD (12,26,9) | 1.27 | Buy |
| Stochastic (14,3,3) | 100 | Sell |
| ADX (14) | 28.5 | Buy |
| Williams %R (14) | 0 | Sell |
| ATR (14) | 0.57 | High Volatility |
| ROC (12) | 115.05 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 93.85 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Draft Letter of Offer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=201D1162-960D-4B96-B7DD-9E0EBD21A416-182440.pdf) |
| 2026-09-03 | [Open Offer - Detailed Public Statement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25CE89C2-9671-461F-8522-B7A5F1E302DB-185319.pdf) |
| 2026-09-02 | [Submission Of Notice Of 10Th Annual General Meeting- Kenrik Industries Limited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5337731-da11-42c8-9107-e95261e28a7e.pdf) |
| 2026-09-02 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08783d2b-f993-4ce7-8b8d-de1389f1ab83.pdf) |
| 2026-09-02 | [Book Closure For The Purpose Of 10Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f5b8b07-87dc-4326-ab5c-6817f3b9b084.pdf) |
| 2026-09-01 | [Board Meeting Outcome for Board Meeting Outcome For Board Meeting Held On 01.09.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21edb4f9-5a29-46ef-a17f-2fdb33730059.pdf) |
| 2026-08-27 | [Open Offer - Public Announcement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=CF0E13EF-DB8A-4C1F-9699-4D9ED03C3107-193004.pdf) |
| 2026-07-15 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10ca81ae-cffc-477f-ac08-21c4e315e794.pdf) |
| 2026-05-30 | [Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On 30Th May 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47850dde-1f04-461c-8614-3f3cfb8d3854.pdf) |
| 2026-05-26 | [Board Meeting Intimation for Board Meeting To Be Held On Saturday 30Th May 2026 To Consider And Approve Financial Results For The Quarter And Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ea25e67-5dc9-415b-9fc7-8b1839fcb699.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-30 | [Audited Financial Results For The Quarter And Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=170479a6-307e-4072-8b48-20b46142d0de.pdf) |
| 2025-11-14 | [Outcome Of Board Meeting Held Today I.E. November 14 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5159aeb9-d5c7-4816-af0d-a61f1957908a.pdf) |
| 2025-05-28 | [Results-Financial Result For The Quarter And Year Ended On 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22abc91c-3ad0-4793-8adf-9dbcba830671.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 October 2025 - Board appointed Santosh Palav (Non‑Executive Director) and Ravindra Salaskar (Whole‑time Director, KMP) effective 09 Oct 2025; Salaskar five-year term. | [Change in Director(s) 9 October 2025 - Board appointed Santosh Palav (Non‑Executive Director) and Ravindra Salaskar (Whole‑time Director, KMP) effective 09 Oct 2025; Salaskar five-year term.](https://nsearchives.nseindia.com/corporate/SAROJAPHARMA_09102025192022_SEIntimationsd12.pdf) |
| 6 Jan - Under Reg.74(5) of SEBI(DP) Regulations,2018 for the quarter ended on 31.12.2025 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Jan - Under Reg.74(5) of SEBI(DP) Regulations,2018 for the quarter ended on 31.12.2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f33d11b-05b5-448f-8c07-d20ef188487a.pdf) |
| 5 Nov 2025 - Board meeting on 14-Nov-2025 to approve unaudited Q2/H1 results ended 30-Sep-2025; trading window closed. | [Board Meeting Intimation for Approval Of Financial Result For The Quarter And Half Year Ended September 30, 2025 5 Nov 2025 - Board meeting on 14-Nov-2025 to approve unaudited Q2/H1 results ended 30-Sep-2025; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ab1c4485-5c35-4f4b-99b0-aaeb9ddf8fa8.pdf) |
| 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for quarter/year ended Mar 31, 2026. | [Closure of Trading Window 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for quarter/year ended Mar 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8dbb8886-5b49-4567-9237-0d7560b56aa6.pdf) |
| 24 Apr - Kenrik Industries confirms it is not a Large Corporate as of 31 March 2026. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 24 Apr - Kenrik Industries confirms it is not a Large Corporate as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/040c5bb5-2b83-4e9e-b69c-63b38769ce2a.pdf) |
| 21 Apr - Company states annual secretarial compliance report is not applicable for FY2026 under SME exemption. | [Compliances-Reg.24(A)-Annual Secretarial Compliance 21 Apr - Company states annual secretarial compliance report is not applicable for FY2026 under SME exemption.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5f88a34f-06f2-44c1-b3e3-366298960790.pdf) |
| 19 October 2025 - Certificate under Reg 74(5) confirming demat/remat details for quarter ended 30 Sep 2025. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 19 October 2025 - Certificate under Reg 74(5) confirming demat/remat details for quarter ended 30 Sep 2025.](https://nsearchives.nseindia.com/corporate/SAROJAPHARMA_19102025214129_745sd1.pdf) |
| 19 January 2026 - Regulation 74(5) certificate from registrar KFIN confirming demat/remat details for quarter ended 31-Dec-2025. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 19 January 2026 - Regulation 74(5) certificate from registrar KFIN confirming demat/remat details for quarter ended 31-Dec-2025.](https://nsearchives.nseindia.com/corporate/SAROJAPHARMA_19012026210631_certificate745sd.pdf) |
| 14 Nov 2025 - Unaudited results for quarter/half-year ended 30 Sep 2025; H1 PAT Rs58.45 lakh. | [Board Meeting Outcome for Result For The Quarter And Half Year Ended September 30, 2025 14 Nov 2025 - Unaudited results for quarter/half-year ended 30 Sep 2025; H1 PAT Rs58.45 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ab1b662a-318c-435d-9336-641783f2a370.pdf) |
| 14 Nov 2025 - No deviation in use of IPO proceeds of Rs.836.25 lakhs raised May 09, 2025, fully utilized. | [Statement Of Deviation Or Variation In Utilization Of Funds Raised Under Regulation 32 Of SEBI (LODR) Regulation, 2015 For Half Year Ended September 30, 2025 14 Nov 2025 - No deviation in use of IPO proceeds of Rs.836.25 lakhs raised May 09, 2025, fully utilized.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cdac7d3f-e204-40b5-96be-461502ceae6a.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28781_SAROJA_2024_2025_A_7662121_06092025172435.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26186_SAROJA_2023_2024_07092024211830.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3f04186b-dfef-48c0-9cfd-b1af951abf54.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:22:57.375Z.